It's really a drug formulated by Hoffmann-La Roche which functions to be a strong and selective adverse allosteric modulator for group II with the metabotropic glutamate receptors (mGluR2/3), being equipotent at mGluR2 and mGluR3 but devoid of exercise at other mGluR subtypes.When more analysis is required on The subject, the early identification o